Observational - Registry
REMEDY was the first large, multi-country registry and cohort study of thousands of people with rheumatic heart disease (RHD) across much of Africa, the Middle East, and East Asia.
The objective of the REMEDY study was to:
Another Co-Principal Investigator on the REMEDY study was Ganesan Karthikeyan, Professor, Cardiology, All India Institute of Medical Sciences.
Observational - Registry
Koon Teo is a Professor of Medicine, Division of Cardiology, McMaster University, and provides senior leadership to PHRI’s direction and research studies. He has served as the acting director of the Division of Cardiology at McMaster University and Hamilton Health Sciences, and Chief of Cardiology, McMaster University Medical Centre. His wide range of work includes 16 book chapters, 356 articles and 280 abstracts featured in more than 15 medical journals worldwide.
He was the Canadian Principal Investigator for the COURAGE trial the results of which impact the practice of cardiology worldwide, and for the Canadian Institute for Health Research funded ongoing FAMILY study examining the origins of obesity and cardiometabolic risk factors in early childhood. He is also co-principal investigator of The International Polycap Study (TIPS).
Sumathy Rangarajan has been Program Director, Global Health, since 2016, preceded by many years’ service at PHRI in other roles. She oversees the PURE study team, as well as the INVICTUS rheumatic AF treatment trial, the CANPWR pediatric weight management registry, and others.
She holds both a Bachelor of Science Degree and a Master of Science degree from Pune University in India.
BONGANI MAYOSI was the world’s foremost authority on interventions for tuberculous pericarditis, who worked with PHRI’s Salim Yusuf in creation of the Pan-African Investigation of the Management of Pericarditis, a multi-center research consortium. Dr. Mayosi’s relationship with PHRI also led to the establishment of the Global Rheumatic Heart Disease Registry (REMEDY), which became the first multi-country registry and cohort study of 3,000 people with RHD across much of Africa, the Middle East, and east Asia.
As well as being appointed Dean, Faculty of Medicine, University of Cape Town, Dr. Mayosi received the Honorary Fellowship of Wolfson College, University of Oxford, and became one of the few Africans inducted to the National Academy of Medicine in the US. He passed away in July 2018.
Back To Top